Switching to subtenon triamcinolone acetonide does not jeopardize the functional and anatomic outcomes of dexamethasone implant treated eyes with diabetic macular edema.
Borella Ysé, Bertaud Samuel, Tadayoni Ramin, Bodaghi Bahram, Dupas Bénédicte, Touhami Sara
Switching from dexamethasone implants to subtenon triamcinolone for diabetic macular edema maintained visual and anatomical outcomes. This suggests STTA is a viable alternative when DEXi is unavailable, offering flexible treatment options.